Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1990; 63(01): 146-147
DOI: 10.1055/s-0038-1645707
DOI: 10.1055/s-0038-1645707
Letter to the Editor
Thrombotic Changes in Haemostasis Following Intravenous Streptokinase Treatment for Acute Myocardial Infarction
Further Information
Publication History
Received 23 August 1989
Accepted 27 October 1989
Publication Date:
02 July 2018 (online)
-
References
- 1 Simoons ML. Thrombolytic therapy in acute myocardial infarction. Ann Rev Med 1989; 40: 181-187
- 2 Bates ER, Topol EJ. Thrombolytic therapy for acute myocardial infarction. Chest 1989; (Suppl. 95) 257-263
- 3 Jusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I Treatment following myocardial infarction. J Am Med Assoc 1988; 260: 2089-2093
- 4 Naylor CD, Armstrong PW. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Can Med Assoc J 1989; 140: 1289-1299
- 5 Hogg KJ. ECG evidence of myocardial salvage after thrombolysis in acute myocardial infarction. Br Heart J 1989; 61: 489-493
- 6 Rapaport SI. A plasma protein C activity assay suitable for clinical laboratory. Am J Clin Pathol 1989; 87: 491-497
- 7 Zimmerman TS. Determination of the von Willebrand’s disease antigen in plasma by quantitative immunoelectrophoresis. J Lab Clin Med 1975; 86: 152-159
- 8 Fitzgerald DJ, Wright F, FitzGerald GA. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane-A2 modulate the response to tissue type plasminogen activator in vivo. Circulation Res 1989; 65: 83-94